Molina Healthcare — Feb 5, 2025 release

• The Company issued its full year 2025 earnings guidance with expected premium revenue of approximately $42 billion and adjusted earnings of at least $24.50 per diluted share, which includes approximately $1.00 per diluted share of implementation costs for recent -MORE- Molina Healthcare, Inc. Reports Fourth Quarter and Year-End 2024 Financial Results Page 2 February 5, 2025 Medicaid and Medicare Duals contract wins scheduled to commence in 2026 and yields approximately 13% growth over 2024. • New store embedded earnings is now at $7.75 per diluted share and reflects recent Medicaid and Medicare Duals contract wins. “I am very pleased our 2024 revenue growth exceeded our long-term targets and we produced consolidated pre-tax margins within our long-term target range,” said Joseph Zubretsky, President and Chief Executive Officer. “Our earnings growth profile is solid heading into 2025, and we continue to execute on the long-term growth opportunities within all of our businesses. We remain confident in our ability to achieve our long-term financial targets.” Premium Revenue Premium revenue was approximately $38.6 billion for the full year 2024, an increase of 19% year over year. The higher premium revenue reflects new contract wins, acquisitions, and growth in our current footprint, partially offset by the impact of Medicaid redeterminations. Net Income GAAP net income for the full year 2024 was $20.42 per diluted share, an increase of 9% year over year. Adjusted net income for the full year 2024 was $22.65 per diluted share, an increase of 8% year over year. Medical Care Ratio (MCR) • The consolidated MCR for the full year 2024 was 89.1% and reflects continued focus o